Cart - OncoTAb

Your cart is currently empty.

Return To Shop

Get Your

Agkura™ Personal Score

Click Here

Does Preoperative Immunotherapy Improve Treatment of Locally Advanced Rectal Cancer?
Immunotherapy May Improve Treatment of Rectal Cancer
Ipatasertib Precision Cancer Medicine for Prostate Cancer
According to the results of a recent clinical study aggressive prostate cancers may be treated more effectively by combining an existing targeted medicine, Zytiga (abiraterone) with a new experimental drug to block two of cancer’s growth signals at once. The combination delayed prostate cancers ...
Could Genomic Testing Identify Breast Cancer Patients Who Can Avoid Adjuvant Radiotherapy?
POLAR Genomic profile suggest some women with early stage breast cancer might avoid radiation therapy.
Tislelizumab in Esophageal Cancer
Tislelizumab improved overall survival compared with investigator-chosen standard chemotherapy in patients with esophageal squamous cell carcinoma, according to data from a phase 3 study presented at the ASCO 2021 Annual Meeting. About TislelizumabTislelizumab (BGB-A317) is a type of precision ...
Elranatamab in Multiple Myeloma
Will bispecific antibodies change the treatment of myeloma?
Mirvetuximab Soravtansine
The Antibody Drug Conjugate Mirvetuximab soravtansine appears promising for treatment of certain patients with ovarian cancer.
Alrizomadlin
Can resistance to immunotherapy be overcome with alrizomadlin?
Pimitespib Treatment for GIST
Novel heat shock protein inhibitor Pimitespib promising for GIST
Afami-cel Elicits Durable Response Rates in Patients with Sarcoma
Novel TCR immunotherapy promising for synovial sarcoma
Rusfertide-a New Option to Avoid Phlebotomy?
Can PV patients avoid phlebotomy?

Get Your

Agkura™ Personal Score

NEWSLETTER

LINKS

ADDRESS

PHONE

EMAIL

Get Your

Agkura™ Personal Score

NEWSLETTER

SOCIAL MEDIA

LINKS

ADDRESS

PHONE

EMAIL